HZSY(SH:600191) Zhi Tong Cai Jing·2025-12-18 09:44Core Viewpoint - The company plans to establish a wholly-owned subsidiary, Baotou Henglu Biotechnology Co., Ltd., with a registered capital of 10 million yuan to advance its development strategy of "innovation-driven, diversified layout, and promoting industrial upgrading" [1] Group 1: Company Strategy - The establishment of the subsidiary aims to enhance the company's product offerings, including xanthan gum and resistant dextrin, which are crucial for the development of skincare products and convenient nutritional meal replacements [1] - The new products will help the company extend its industrial chain and improve its product value chain [1] Group 2: Technological Collaboration - The subsidiary will leverage existing resources such as the Baotou Huazi Synthetic Biology and Microbial Modification Technology Academician Workstation and the collaborative "Technology Demonstration Base" with the Chinese Academy of Sciences [1] - The company plans to work closely with industry experts, scholars, and research institutions to track cutting-edge technologies and industry trends in biological fermentation and health products [1]